A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.

Clinical trial NCT06064812 · RECRUITING

Trial details

NCT number: NCT06064812
Sponsor: Forward Pharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Locally Advanced Breast Cancer Breast Cancer Stage IV ER+/HER2- Breast Cancer

Start date: 2023-09-12
Primary completion: 2026-03-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.